Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters

PHASE3CompletedINTERVENTIONAL
Enrollment

1,859

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

July 31, 2008

Conditions
Infection
Interventions
DRUG

Omiganan 1% gel

Patients randomized to omiganan group will receive an application of omiganan gel around the catheter insertion site following catheter insertion. Every 3 days the dressing will be changed and patients will receive a new application of Omiganan 1% gel.

DRUG

Povidone-Iodine 10%

All CVC sites will be disinfected using a 10% povidone-iodine scrub for a minimum of 2 minutes prior to catheter insertion. Patients randomized to the povidone-iodine group will receive no further antiseptic treatment after catheter insertion until dressing changes. Every three days the dressing will be changed and the catheter site will be sterilized with povidone-iodine.

Trial Locations (57)

Unknown

Mobile

Phoenix

Arcadia

Glendale

Long Beach

Los Angeles

Madera

San Diego

San Francisco

Torrance

Denver

Bridgeport

Jacksonville

Miami

Fort Gordon

Marietta

Elk Grove Village

Hoffman Estates

Louisville

Opelousas

Shreveport

Saint Paul

Kansas City

Camden

Newark

Brooklyn

Jamaica

Syracuse

Oklahoma City

Pittsburgh

Memphis

El Paso

Fort Worth

Houston

Lubbock

Morgantown

Bourg-en-Bresse

Brive-la-Gaillarde

La Roche-sur-Yon

Limoges

Montauban

Orléans

Pau

Poitiers

Tours

Halle

Jena

Leipzig

Regensburg

Alcalá de Henares

Barcelona

Cadiz

El Palmar (Murcia)

Las Palmas de Gran Canaria

Madrid

Palma de Mallorca

Seville

Sponsors
All Listed Sponsors
lead

Cadence Pharmaceuticals

INDUSTRY

NCT00231153 - Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters | Biotech Hunter | Biotech Hunter